Related Experiment Video

Updated: Jul 13, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

[Treatment of atrial fibrillation]

P Kirchhof1, G Breithardt

  • 1Medizinische Klinik und Poliklinik C, Kardiologie und Angiologie, Universitätsklinikum Münster, Albert-Schweitzer-Strasse 33, 48149 Münster. kirchhp@uni-muenster.de

Der Internist
|July 17, 2007
PubMed

Insights

Atrial fibrillation (AF) management involves stroke prevention with anticoagulation and symptom relief. Rhythm control therapies, including drugs and pulmonary vein isolation, aim to maintain sinus rhythm and improve patient outcomes.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Atrial fibrillation (AF) is a prevalent, often recurrent arrhythmia associated with increased mortality and severe symptoms.
  • Stroke prevention through timely oral anticoagulation is crucial for AF patients identified as high-risk via scoring systems like CHADS(2).

Purpose of the Study:

  • To review current strategies for managing atrial fibrillation, focusing on stroke prevention and rhythm control.
  • To highlight the role of pharmacological and interventional therapies in maintaining sinus rhythm and improving patient prognosis.

Main Methods:

  • Review of existing literature on atrial fibrillation management.
  • Discussion of clinical scoring systems for stroke risk assessment.
  • Evaluation of pharmacological treatments, including rate and rhythm control agents.
  • Assessment of interventional procedures like catheter ablation for pulmonary vein isolation.

Main Results:

  • Anticoagulation effectively prevents thromboembolic complications in at-risk AF patients.
  • Drugs slowing AV nodal conduction alleviate symptoms related to rapid ventricular rates.
  • Cardioversion can acutely restore sinus rhythm, but recurrences are common.
  • Antiarrhythmic drugs and certain other agents (ACE inhibitors, sartans, statins) improve sinus rhythm maintenance.
  • Pulmonary vein isolation offers a potential cure for some AF patients.

Conclusions:

  • A multimodal therapeutic approach combining anticoagulation, rate control, rhythm control, and potentially catheter ablation is essential for effective atrial fibrillation management.
  • Future strategies likely involve integrating these therapies for enhanced rhythm control and improved long-term outcomes in AF patients.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...